期刊文献+

制备淋巴瘤多基因肿瘤疫苗的方法学探索

Studies on the Preparation of Polygene Tumor Vaccine for Lymphoma
下载PDF
导出
摘要 目的探讨用于淋巴瘤的多基因肿瘤疫苗的制作方式及淋巴瘤的基因治疗方法。方法采用腺病毒转染、脂质体辅助转染、脂质体辅助腺病毒转染的方式,将带GFP的载体转染B系淋巴瘤A20细胞株,并以Hela细胞作为对照,荧光显微镜下观察转染效率。将B7-1与CD40L表达载体联合导入A20荷瘤小鼠肿瘤内,观察肿瘤生长情况,应用肿瘤病理切片和HE染色技术观察肿瘤组织形态及淋巴细胞浸润情况。结果对A20细胞而言,单纯脂质体和单纯腺病毒转染效率均非常低,脂质体辅助腺病毒转染效率有所提高。但均显著低于采用腺病毒转染Hela细胞。瘤内联合注射B7-1和CD40L表达载体可导致肿瘤生长延缓及体积缩小,肿瘤消退效应较明显。肿瘤形态学观察表明,治疗小鼠肿瘤局部有炎性细胞浸润并伴有大面积的坏死,肿瘤局限化。结论B系淋巴瘤细胞株难于通过体外基因导入制作肿瘤疫苗,脂质体辅助腺病毒转染效果较好,质粒载体瘤内注射可作为一种安全有效的肿瘤疫苗作用方式。 Objective To study the preparation polygene tumor vaccine and the genetherapy for lymphoma. Methods GFP were transected into A20 cells with adenovirus, lipofectin and adenovirus with lipofectin assistant, and Hela cell lines were used as control. After 48 ~ 72 hours, the cells were observed under the fluorescence microscope to determine the efficiency of transfection. B7-1 and CD40L expression vectors in combination were directly injected into lymphomas of A420 mice model, the histological characteristics and the cell infiltration in lymphoma were observed. Results In the A20 cells, either the cells transected by lipofectin or adenovirus alone resulted in a very low efficiency. When adenovirus transected GFP were used with lipofectin assistant, the efficiency became higher. However, it is always far lower than that in Hela' s. Intratumoral injection of B7-1 and CD40L plasmids which resulted in reduction of tumor size. Morphological observation revealed inflammatory cell infiltration in the tumors, massive necrosis and localization of tumor. Condusion It is difficult to make tumor vaccine for lymphoma by transferring the gene into the cells in vitro. Although adenovirus with lipofectin assistant attains higher transfection efficiency, it is not sufficient, the intratumoral injection may be considered as a safe and effective way of tumor vaccine administration.
出处 《首都医科大学学报》 CAS 2008年第2期118-123,共6页 Journal of Capital Medical University
基金 国家自然科学基金(30371579)资助项目~~
关键词 淋巴瘤 肿瘤疫苗 基因治疗 腺病毒 脂质体 B7-1 CD40L lymphoma tumor-vaccine gene-therapy adenovirus lipofectin BT-1 CD40L
  • 相关文献

参考文献12

  • 1Raez L E, Cassileth P A, Schlessel,nan J J, et al. Allogeneic vaccination with a B7-1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced nou-small-cell lung cancer[J].J Clin Oncol, 2004,22:2800- 2807.
  • 2Takahiro K, Toya O, Tetsuro K, et al. Antitumor immunily against bladder cancer induced by exvivo expression of CD40 ligand gene using retrovirus vector[J]. Cancer Gene Therapy, 2003,10:833-839.
  • 3Buttgereit P, Weineck S, Ropke G, et al. Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection [ J ]. Cancer Gene Ther, 2000, 7:1145-1155.
  • 4Hellebrand E, Mautner J, Reisbach G, et al. Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination[ J]. Gene Ther, 2006,13: 150-162.
  • 5Wendtner C M, Kofler D M, Theiss H D, et al. Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus ( rAAV ) vectors [ J ]. Blood, 2002,100 : 1655- 1661.
  • 6Bovia F, Salmon P, Matthes T, et al. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors [ J]. Blood, 2003,101:1727- 1733.
  • 7Ebert O, Wilbert D, Buttgereit P, et al. Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMC [ J ]. Genet Vaccines Ther, 2004,2 : 15.
  • 8王凯,彭建强,袁振华,吴小兵.AD5/F35腺病毒载体对不同来源造血系统恶性细胞转染效率的研究[J].中国实验血液学杂志,2006,14(3):525-528. 被引量:6
  • 9Zhou Z F, Peretz Y, Chang Y, et al. Intramuscular gene transfer of soluble B7-1/IgG( 1 ) fusion cDNA induces potent antitumor immunity as an adjuvant for DNA vaccination [ J]. Cancer Gene Ther, 2003,10:491-499.
  • 10Vasilevko V, Ghochikyan A, Sadzikava N, et al. Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumors [ J]. Clin Exp Metastasis, 2003,20:489-498.

二级参考文献15

  • 1Shayakhmtov DM,Papayannopoulou T,Stamatoyannopoulou G,et al.Efficient gene transfer into human CD34 + cell by a retargeted adenovirus vector.J Virol,2000; 74:2567-2583
  • 2Segerman A,Arnberg N,Erikson A,et al.There are two different species B adenovirus receptors:sBAR,common to species B1 and B2 adenoviruses,and sB2AR,exclusively used by species B2 adenovirus.J Virol,2003; 77:1157-1162
  • 3Segerman A,Atkinson JP,Marttila M,et al.Adenovirus type 11uses CD46 as a cellular receptor.J Virol,2003; 77:9183 -9191
  • 4Shayakhmtov DM,Li ZY,Ternovoi V,et al.The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenovirus.J Virol,2003:77:3712-3723
  • 5Sirena D,Lilienfeld B,Eisenhut M,et al.The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3.J Virol,2004; 78:4454-4462
  • 6Boussiotis VA, Freeman GJ, Gray G, et al. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med, 1993; 178:1753- 1763
  • 7Bretscher P. The two-signal model of lymphocyte activation twenty one years later. Immunol Today, 1992; 13:74-76
  • 8Freeman GJ, Boussiotis VA, Anumanthan A, et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7 1 preferentially costimulates the initial production of IL-4. Immunity, 1995; 2:523- 532
  • 9Mueller DL, Jenkine MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway de termines the outcome of T cell antigen receptor occupancy. AnnuRev Immunol, 1989; 7:445 - 480
  • 10Kuchroo VK, Martin CA, Greer JM, et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-spe cific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol, 1993; 151:4371-4382

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部